Drug Shortage Report for ACETYLCYSTEINE SOLUTION USP

Last updated on 2018-09-04 History
Report ID 55518
Drug Identification Number 02459906
Brand name ACETYLCYSTEINE SOLUTION USP
Common or Proper name Acetylcysteine Solution USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACETYLCYSTEINE
Strength(s) 200MG
Dosage form(s) SOLUTION
Route of administration INHALATION INTRAVENOUS ORAL
Packaging size 10 mL
ATC code R05CB
ATC description EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-12
Estimated end date 2018-08-29
Actual end date 2018-08-29
Shortage status Resolved
Updated date 2018-09-04
Company comments Alveda DIN 02300435 Acetylcysteine Injection 200 mg/mL is discontinued. Product will be available as Teligent DIN 02459906 Acetylcysteine Solution USP will be in stock July 22 2018.
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-07-12 English Compare
v2 2018-07-12 English Compare
v3 2018-07-12 English Compare
v4 2018-07-12 French Compare
v5 2018-08-10 English Compare
v6 2018-08-10 French Compare
v7 2018-08-22 English Compare
v8 2018-08-22 French Compare
v9 2018-09-04 English Compare
v10 2018-09-04 French Compare

Showing 1 to 10 of 10